In
early 2006, the positive results of a small preliminary
trial on
GlucosRx™ convinced the formulators to invest
in a larger Phase
1, Randomized, Double-Blind, Placebo Controlled, Human
Clinical Study.
The
study was designed primarily to examine how well
GlucosRx™ works
with the body to promote healthy blood sugar by measuring
response
in a glucose challenge
test, A1c, and other biological markers.
Secondarily,
the study examined how well GlucosRx™ works
with the body to promote healthy triglyceride, cholesterol,
and blood pressure health. The study began in June
2007 and concluded in September 2007.
The study also
measured 14, 30, 60, and 90 day fasting
blood sugar levels. The 90 day reading supplied A1c
levels that were compared to those taken at the start
of the
study.
The final study
results are so positive that they
are hard to believe!
We invite you to
review the complete GlucosRx™ clinical trial
report and peer review.
|